{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:25Z","timestamp":1794047425423,"version":"4.8.0"},"reference-count":23,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"8","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>The prognosis of aggressive adult T-cell leukemia\/lymphoma (ATL) is poor, and allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment. In order to identify favorable prognostic patients after intensive chemotherapy, and who therefore might not require upfront allo-HSCT, we aimed to improve risk stratification of aggressive ATL patients aged &lt;70 years. The clinical risk factors and genetic mutations were incorporated into risk modeling for overall survival (OS). We generated the m7-ATLPI, a clinicogenetic risk model for OS, that included the ATL prognostic index (PI) (ATL-PI) risk category, and non-silent mutations in seven genes, namely TP53, IRF4, RHOA, PRKCB, CARD11, CCR7, and GATA3. In the training cohort of 99 patients, the m7-ATLPI identified a low-, intermediate-, and highrisk group with 2-year OS of 100%, 43%, and 19%, respectively (hazard ratio [HR] =5.46; P&lt;0.0001). The m7-ATLPI achieved superior risk stratification compared to the current ATL-PI (C-index 0.92 vs. 0.85, respectively). In the validation cohort of 84 patients, the m7-ATLPI defined low-, intermediate-, and high-risk groups with a 2-year OS of 81%, 30%, and 0%, respectively (HR=2.33; P=0.0094), and the model again outperformed the ATL-PI (C-index 0.72 vs. 0.70, respectively). The simplified m7-ATLPI, which is easier to use in clinical practice, achieved superior risk stratification compared to the ATLPI, as did the original m7-ATLPI; the simplified version was calculated by summing the following: high-risk ATL-PI category (+10), low-risk ATL-PI category (\u22124), and non-silent mutations in TP53 (+4), IRF4 (+3), RHOA (+1), PRKCB (+1), CARD11 (+0.5), CCR7 (\u22122), and GATA3 (\u22123).<\/jats:p>","DOI":"10.3324\/haematol.2022.281510","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T03:43:35Z","timestamp":1676519015000},"page":"2178-2191","source":"Crossref","is-referenced-by-count":14,"title":["Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia\/lymphoma"],"prefix":"10.3324","volume":"108","author":[{"given":"Takuro","family":"Kameda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Kamiunten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kisato","family":"Nosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Yoshimitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichirou","family":"Yasunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Kogure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Shide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Miyahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Akizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Kubuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Koya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouichi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Marutsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Sugio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukie","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ishitsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kitanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atae","family":"Utsunomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seishi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"key":"50648","doi-asserted-by":"crossref","unstructured":"Uchiyama T, Yodoi J, Sagawa K. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977; 50(3):481-492.","DOI":"10.1182\/blood.V50.3.481.481"},{"key":"50649","doi-asserted-by":"crossref","unstructured":"Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol. 1991; 79(3):428-437.","DOI":"10.1111\/j.1365-2141.1991.tb08051.x"},{"key":"50650","unstructured":"Shimoyama M. Chemotherapy of ATL. K Takatsuki (Ed), Adult T-Cell Leukemia, Oxford University Press. Oxford. 1994;221-227."},{"key":"50651","doi-asserted-by":"crossref","unstructured":"Cook LB, Fuji S, Hermine O. Revised Adult T-cell Leukemia-Lymphoma International Consensus Meeting Report. J Clin Oncol. 2019; 37(8):677-687.","DOI":"10.1200\/JCO.18.00501"},{"key":"50652","doi-asserted-by":"crossref","unstructured":"Tsukasaki K, Utsunomiya A, Fukuda H. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol. 2007; 25(34):5458-5464.","DOI":"10.1200\/JCO.2007.11.9958"},{"key":"50653","doi-asserted-by":"crossref","unstructured":"Sekine M, Kameda T, Shide K. Higher average chemotherapy dose intensity improves prognosis in patients with aggressive adult T-cell leukemia\/lymphoma. Eur J Haematol. 2021; 106(3):398-407.","DOI":"10.1111\/ejh.13565"},{"key":"50654","doi-asserted-by":"crossref","unstructured":"Katsuya H, Ishitsuka K, Utsunomiya A. Treatment and survival among 1594 patients with ATL. Blood. 2015; 126(24):2570-2577.","DOI":"10.1182\/blood-2015-03-632489"},{"key":"50655","doi-asserted-by":"crossref","unstructured":"Utsunomiya A, Miyazaki Y, Takatsuka Y. Improved outcome of adult T cell leukemia\/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001; 27(1):15-20.","DOI":"10.1038\/sj.bmt.1702731"},{"key":"50656","doi-asserted-by":"crossref","unstructured":"Hishizawa M, Kanda J, Utsunomiya A. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood. 2010; 116(8):1369-1376.","DOI":"10.1182\/blood-2009-10-247510"},{"key":"50657","doi-asserted-by":"crossref","unstructured":"Fuji S, Fujiwara H, Nakano N. Early application of related SCT might improve clinical outcome in adult T-cell leukemia\/lymphoma. Bone Marrow Transplant. 2016; 51(2):205-211.","DOI":"10.1038\/bmt.2015.265"},{"key":"50658","doi-asserted-by":"crossref","unstructured":"Fukushima T, Nomura S, Shimoyama M. Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A). Br J Haematol. 2014; 166(5):739-748.","DOI":"10.1111\/bjh.12962"},{"key":"50659","doi-asserted-by":"crossref","unstructured":"Katsuya H, Yamanaka T, Ishitsuka K. Prognostic index for acute- and lymphoma-type adult T-cell leukemia\/lymphoma. J Clin Oncol. 2012; 30(14):1635-1640.","DOI":"10.1200\/JCO.2011.38.2101"},{"key":"50660","doi-asserted-by":"crossref","unstructured":"Fuji S, Yamaguchi T, Inoue Y. Development of a modified prognostic index of patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: a possible risk-adapted management strategies including allogeneic transplantation. Haematologica. 2017; 102(7):1258-1265.","DOI":"10.3324\/haematol.2017.164996"},{"key":"50661","doi-asserted-by":"crossref","unstructured":"Kataoka K, Nagata Y, Kitanaka A. Integrated molecular analysis of adult T cell leukemia\/lymphoma. Nat Genet. 2015; 47(11):1304-1315.","DOI":"10.1038\/ng.3428"},{"key":"50662","doi-asserted-by":"crossref","unstructured":"Kogure Y, Kameda T, Koya J. Whole-genome landscape of adult T-cell leukemia\/lymphoma. Blood. 2022; 139(7):967-982.","DOI":"10.1182\/blood.2021013568"},{"key":"50663","doi-asserted-by":"crossref","unstructured":"Kataoka K, Shiraishi Y, Takeda Y. Aberrant PD-L1 expression through 3'-UTR disruption in multiple cancers. Nature. 2016; 534(7607):402-406.","DOI":"10.1038\/nature18294"},{"key":"50664","doi-asserted-by":"crossref","unstructured":"Kataoka K, Iwanaga M, Yasunaga JI. Prognostic relevance of integrated genetic profiling in adult T-cell leukemia\/lymphoma. Blood. 2018; 131(2):215-225.","DOI":"10.1182\/blood-2017-01-761874"},{"key":"50665","doi-asserted-by":"crossref","unstructured":"Reddy A, Zhang J, Davis NS. Genetic and functional drivers of diffuse large B cell lymphoma. Cell. 2017; 171(2):481-494.","DOI":"10.1016\/j.cell.2017.09.027"},{"key":"50666","doi-asserted-by":"crossref","unstructured":"Sakamoto Y, Ishida T, Masaki A. CCR4 mutations associated with superior outcome of adult T-cell leukemia\/lymphoma under mogamulizumab treatment. Blood. 2018; 132(7):758-761.","DOI":"10.1182\/blood-2018-02-835991"},{"key":"50667","doi-asserted-by":"crossref","unstructured":"Persky DO, Li H, Stephens DM. Positron emission tomography-directed therapy for patients with limited-stage diffuse large B-cell lymphoma: results of intergroup National Clinical Trials Network Study S1001. J Clin Oncol. 2020; 38(26):3003-3011.","DOI":"10.1200\/JCO.20.00999"},{"key":"50668","doi-asserted-by":"crossref","unstructured":"Relander T, Johnson NA, Farinha P. Prognostic factors in follicular lymphoma. J Clin Oncol. 2010; 28(17):2902-2913.","DOI":"10.1200\/JCO.2009.26.1693"},{"key":"50669","doi-asserted-by":"crossref","unstructured":"Pastore A, Jurinovic V, Kridel R. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry. Lancet Oncol. 2015; 16(9):1111-1122.","DOI":"10.1016\/S1470-2045(15)00169-2"},{"key":"50670","doi-asserted-by":"crossref","unstructured":"Sakihama S, Morichika K, Saito R. Genetic profile of adult T-cell leukemia\/lymphoma in Okinawa: association with prognosis, ethnicity, and HTLV-1 strains. Cancer Sci. 2021; 112(3):1300-1309.","DOI":"10.1111\/cas.14806"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.281510\/75345","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.281510\/75890","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/10979\/75345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:03:33Z","timestamp":1794045813000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2022.281510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":23,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2022.281510","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,16]]}}}